Texas 2009 - 81st Regular

Texas House Bill HB4402

Filed
 
Out of House Committee
4/27/09  
Voted on by House
5/6/09  
Out of Senate Committee
5/19/09  
Voted on by Senate
5/26/09  
Governor Action
6/19/09  
Bill Becomes Law
 
Enrolled
5/29/09  

Caption

Relating to a study regarding insurance coverage of prescription drugs provided under a health benefit plan.

Impact

The law, once enacted, will apply to health benefit plans delivered, issued for delivery, or renewed after January 1, 2010. Plans that were delivered, issued, or renewed prior to this date will continue to follow existing laws. This forward-looking approach aims to create a more stable environment for patients relying on prescription medications, protecting them from unexpected changes that could affect their treatment regimens. This law emphasizes the need for a predictable health insurance landscape where enrollees can maintain necessary prescriptions without fear of sudden denial or increased financial burden.

Summary

House Bill 4402 addresses changes in insurance coverage for prescription drugs under health benefit plans in Texas. The bill prohibits health insurance issuers from limiting, reducing, or denying coverage for a prescription drug if the enrollee is currently using the drug and is entitled to coverage. Specifically, it seeks to protect enrollees from adverse changes in prescription drug coverage, such as the removal of a drug from a formulary, new prior authorization requirements, or increases in cost-sharing obligations for covered drugs. This is a significant shift towards ensuring that patients have consistent access to necessary medications without abrupt changes in their coverage.

Contention

In discussions surrounding HB4402, there may be some contention regarding the balance between insurers' abilities to manage drug formularies and the rights of enrollees to uninterrupted access to prescribed medications. Supporters argue that this measure is essential for patient welfare, particularly for those with chronic conditions requiring consistent medication. However, opponents may express concerns about potential impacts on insurance providers' cost management strategies, as the bill could limit their flexibility in controlling drug costs and maintaining formularies. The ongoing debate reflects broader discussions in healthcare about access, affordability, and the role of insurance in health management.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.